CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
JOURNAL OF CLINICAL ONCOLOGY (2017)
期刊
JOURNAL OF CLINICAL ONCOLOGY
卷 35, 期 29, 页码 3330-+出版社
AMER SOC CLINICAL ONCOLOGY
关键词
类别
资金
- Roche Pharma AG
- German Cancer Society (section AIO)
- Charite-Universitatsmedizin Berlin
作者
我是这篇论文的作者
推荐
Original Research Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma-A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials
Annika Kurreck, Johanna Weckwerth, Dominik P. Modest, Jana K. Striefler, Marcus Bahra, Sven Bischoff, Uwe Pelzer, Helmut Oettle, Stephan Kruger, Hanno Riess, Marianne Sinn
EUROPEAN JOURNAL OF CANCER (2021)
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
K. Hoyer, R. Hablesreiter, Y. Inoue, K. Yoshida, F. Briest, F. Christen, N. Kakiuchi, T. Yoshizato, Y. Shiozawa, Y. Shiraishi, J. K. Striefler, S. Bischoff, P. Lohneis, H. Putter, O. Blau, U. Keilholz, L. Bullinger, U. Pelzer, M. Hummel, H. Riess, S. Ogawa, M. Sinn, F. Damm
EBIOMEDICINE (2021)
Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection
Jinming Shi, Wenzhe Kang, Yuan Tang, Ning Li, Liming Jiang, Lin Yang, Shulian Wang, Yongwen Song, Yueping Liu, Hui Fang, Ningning Lu, Shunan Qi, Bo Chen, Yexiong Li, Yantao Tian, Jing Jin
FRONTIERS IN ONCOLOGY (2022)
Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma
Evelien J. M. de Jong, Quisette P. Janssen, Tessa F. A. Simons, Marc G. Besselink, Bert A. Bonsing, Stefan A. W. Bouwense, Sandra M. E. Geurts, Marjolein Y. Homs, Vincent E. de Meijer, Vivianne C. G. Tjan-Heijnen, Hanneke W. M. van Laarhoven, Liselot B. J. Valkenburg-van Iersel, Johanna W. Wilmink, Lydia G. van der Geest, Bas Groot Koerkamp, Judith de Vos-Geelen
INTERNATIONAL JOURNAL OF CANCER (2022)
Survival Outcomes of Gemcitabine Plus S-1 Adjuvant Chemotherapy after Surgical Resection for Advanced Biliary Tract Cancer
Kiyotaka Hosoda, Kentaro Fukushima, Akira Shimizu, Hiroaki Motoyama, Koji Kubota, Tsuyoshi Notake, Shinsuke Sugenoya, Hikaru Hayashi, Koya Yasukawa, Ryoichiro Kobayashi, Yuji Soejima
ONCOLOGY (2021)
FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases - The PARLIM trial (AIO KRK 0314)
Dominik Paul Modest, Meinolf Karthaus, Stefan Kasper, Nicolas Moosmann, Verena Keitel, Alexander Kiani, Jens Uhlig, Lutz Jacobasch, Ludwig Fischer Weikersthal, Martin Fuchs, Florian Kaiser, Christian Lerchenmueller, Dagmar Sent, Christian Junghanss, Swantje Held, Sylvie Lorenzen, Klaus Kaczirek, Andreas Jung, Sebastian Stintzing, Volker Heinemann
EUROPEAN JOURNAL OF CANCER (2022)
Prospective Multicenter Interventional Study of Surgical Resection for Liver Metastasis from Gastric Cancer: R0 Resection Rate, and Operative Morbidity and Mortality
Kazumasa Fujitani, Yukinori Kurokawa, Atsushi Takeno, Ryohei Kawabata, Takeshi Omori, Hiroshi Imamura, Motohiro Hirao, Shunji Endo, Junji Kawada, Jeong Ho Moon, Noboru Kobayashi, Tsuyoshi Takahashi, Makoto Yamasaki, Shuji Takiguchi, Masaki Mori, Hidetoshi Eguchi, Yuichiro Doki
ANNALS OF SURGICAL ONCOLOGY (2022)
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non-Small Cell Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open-Label, Randomized, Multicenter, Phase 3 Study
Xue Hou, Meichen Li, Guowu Wu, Weineng Feng, Jin Su, Honghua Jiang, Guanming Jiang, Jing Chen, Baishen Zhang, Zhixuan You, Qing Liu, Likun Chen
JAMA NETWORK OPEN (2023)
CT-based nomogram for predicting survival after R0 resection in patients with gallbladder cancer: a retrospective multicenter analysis
Seo-Youn Choi, Jung Hoon Kim, Sanghyeok Lim, Ji Eun Lee, Hyun Jeong Park, Bora Lee
EUROPEAN RADIOLOGY (2021)
Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
Sora Kang, Changhoon Yoo, So Heun Lee, Dongwook Oh, Tae Jun Song, Sang Soo Lee, Jae Ho Jeong, Do Hyun Park, Dong Wan Seo, Jin-hong Park, Dae Wook Hwang, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Bong Jun Kwak, Sarang Hong, Heung-Moon Chang, Baek-Yeol Ryoo, Kyu-pyo Kim, Song Cheol Kim
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)
Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial
Hyehyun Jeong, Kyu-pyo Kim, Jae Ho Jeong, Dae Wook Hwang, Jae Hoon Lee, Ki-Hun Kim, Deok-Bog Moon, Myung Ah Lee, Se Jun Park, Hong Jae Chon, Jin-hong Park, Ji Sung Lee, Baek-Yeol Ryoo, Changhoon Yoo
HEPATOLOGY (2023)
Gemcitabine plus Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
Simon Zaibet, Vincent Hautefeuille, Edouard Auclin, Astrid Lievre, David Tougeron, Mathieu Sarabi, Marine Gilabert, Julie Wasselin, Julien Edeline, Pascal Artru, Dominique Bechade, Clemence Morin, Agnes Ducoulombier, Julien Taieb, Simon Pernot
BRITISH JOURNAL OF CANCER (2022)
Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer
Satoshi Kobayashi, Motoko Suzuki, Makoto Ueno, Yuta Maruki, Naohiro Okano, Akiko Todaka, Masato Ozaka, Kunihiro Tsuji, Kazuhiko Shioji, Keitaro Doi, Yasushi Kojima, Hidetaka Tsumura, Kazunari Tanaka, Hajime Higuchi, Ken Kawabe, Hiroshi Imaoka, Tatsuya Yamashita, Haruo Miwa, Hiroaki Nagano, Shiho Arima, Hideyuki Hayashi, Atsushi Naganuma, Hironori Yamaguchi, Terumasa Hisano, Kumiko Umemoto, Shuji Ishii, Koji Nakashima, Rei Suzuki, Yohei Kitano, Toshihiro Misumi, Junji Furuse, Hiroshi Ishii
ONCOLOGIST (2022)
Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic cancer: a real-world study
Haorui Li, Yu Guo, Xugang Sun, Yang Lu, Shaofei Chang, Xiuchao Wang, Song Gao, Chuntao Gao, Tiansuo Zhao
FRONTIERS IN ONCOLOGY (2023)
EGFR inhibitor erlotinib plus monoclonal antibody versus erlotinib alone for first-line treatment of advanced non-small cell lung carcinoma: A systematic review and meta-analysis
Mohan Liu, Kaiwen Xiao, Li Yang
INTERNATIONAL IMMUNOPHARMACOLOGY (2023)
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study
Dietger Niederwieser, Thomas Lang, Rainer Krahl, Thomas Heinicke, Georg Maschmeyer, Haifa Kathrin Al-Ali, Sebastian Schwind, Madlen Jentzsch, Michael Cross, Christoph Kahl, Hans-Heinrich Wolf, Herbert Sayer, Antje Schulze, Peter Dreger, Ute Hegenbart, Alwin Kraemer, Christian Junghanss, Lars-Olof Muegge, Detlev Haehling, Carsten Hirt, Christian Spaeth, Norma Peter, Bernhard Opitz, Axel Florschuetz, Kolja Reifenrath, Niklas Zojer, Sebastian Scholl, Wolfram Poenisch, Simone Heyn, Vladan Vucinic, Andreas Hochhaus, Carlo Aul, Aristoteles Giagounidis, Leopold Balleisen, Bernd Oldenkott, Peter Staib, Michael Kiehl, Wolfgang Schuette, Ralph Naumann, Hartmut Eimermacher, Bernd Doerken, Cristina Sauerland, Eva Lengfelder, Wolfgang Hiddemann, Bernhard Woermann, Carsten Mueller-Tidow, Hubert Serve, Christoph Schliemann, Ruediger Hehlmann, Wolfgang E. Berdel, Markus Pfirrmann, Utz Krug, Verena S. Hoffmann
ANNALS OF HEMATOLOGY (2023)
Adjuvant nab-Paclitaxel plus Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open -Label, Phase III Trial
Margaret A. Tempero, Uwe Pelzer, Eileen M. O'Reilly, Jordan Winter, Do-Youn Oh, Chung-Pin Li, Giampaolo Tortora, Heung-Moon Chang, Charles D. Lopez, Tanios Bekaii-Saab, Andrew H. Ko, Armando Santoro, Joon Oh Park, Marcus S. Noel, Giovanni Luca Frassineti, Yan-Shen Shan, Andrew Dean, Hanno Riess, Eric Van Cutsem, Jordan Berlin, Philip Philip, Malcolm Moore, David Goldstein, Josep Tabernero, Mingyu Li, Stefano Ferrara, Yvan Le Bruchec, George Zhang, Brian Lu, Andrew V. Biankin, Michele Reni
JOURNAL OF CLINICAL ONCOLOGY (2023)
Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial
Rolf D. Issels, Stefan Boeck, Uwe Pelzer, Ulrich Mansmann, Pirus Ghadjar, Lars H. Lindner, Markus Albertsmeier, Martin K. Angele, Michael Schmidt, Yujun Xu, Marcus Bahra, Johann Pratschke, Michael Schoenberg, Wolfgang E. Thasler, Christoph Salat, Oliver J. Stoetzer, Wolfram T. Knoefel, Dirk Graf, Rudiger Wessalowski, Verena Keitel-Anselmino, Alfred Koenigsrainer, Michael Bitzer, Daniel Zips, Michael Bamberg, Rainer Fietkau, Oliver Ott, Maciej Kawecki, Lucian Wyrwicz, Piotr Rutkowski, Markus Rentsch, Juliana Ababei, Peter Reichardt, Marco Rigamonti, Bernhard Weber, Sultan Abdel-Rahman, Katharina Tschoep-Lechner, Karl-Walter Jauch, Christiane J. Bruns, Helmut Oettle, Michael von Bergwelt-Baildon, Volker Heinemann, Jens Werner
EUROPEAN JOURNAL OF CANCER (2023)
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Jannik Stemler, Sibylle C. Mellinghoff, Yascha Khodamoradi, Rosanne Sprute, Annika Y. Classen, Sonja E. Zapke, Martin Hoenigl, Robert Krause, Martin Schmidt-Hieber, Werner J. Heinz, Michael Klein, Philipp Koehler, Blasius Liss, Michael Koldehoff, Christoph Buhl, Olaf Penack, Georg Maschmeyer, Enrico Schalk, Cornelia Lass-Floerl, Meinolf Karthaus, Markus Ruhnke, Oliver A. Cornely, Daniel Teschner
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliarytract cancer (KEYNOTE-966) : a randomised, double-blind, placebo-controlled, phase 3 trial
Robin Kate Kelley, Makoto Ueno, Changhoon Yoo, Richard S. Finn, Junji Furuse, Zhenggang Ren, Thomas Yau, Heinz-Josef Klumpen, Stephen L. Chan, Masato Ozaka, Chris Verslype, Mohamed Bouattour, Joon Oh Park, Olga Barajas, Uwe Pelzer, Juan W. Valle, Li Yu, Usha Malhotra, Abby B. Siegel, Julien Edeline, Arndt Vogel
LANCET (2023)
Internal drainage for interdisciplinary management of anastomotic leakage after pancreaticogastrostomy
Matthaus Felsenstein, Ann-Christin Amini, Sophie Dorfer, Mengwen Hu, Ruonan Wang, Lea Timmermann, Karl Herbert Hillebrandt, Christian Benzing, Uli Fehrenbach, Uwe Pelzer, Igor Maximillian Sauer, Johann Pratschke, Christian Juergensen, Thomas Malinka
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2023)
Treatment of Non-Anastomotic Biliary Strictures after Liver Transplantation: How Effective Is Our Current Treatment Strategy?
Florian A. Michael, Mireen Friedrich-Rust, Hans-Peter Erasmus, Christiana Graf, Olivier Ballo, Mate Knabe, Dirk Walter, Christoph D. Steup, Marcus M. Muecke, Victoria T. Muecke, Kai H. Peiffer, Esra Goerguelue, Antonia Mondorf, Wolf O. Bechstein, Natalie Filmann, Stefan Zeuzem, Joerg Bojunga, Fabian Finkelmeier
JOURNAL OF CLINICAL MEDICINE (2023)
Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients-A Single Center Analysis of 2323 Patients within the Last Decade
Christopher C. M. Neumann, Francois Schneider, Georg Hilfenhaus, Loredana Vecchione, Christian Benzing, Jana Ihlow, Uli Fehrenbach, Thomas Malinka, Ulrich Keilholz, Sebastian Stintzing, Uwe Pelzer
JOURNAL OF CLINICAL MEDICINE (2023)
Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients-A Single-Center Analysis of 1294 Patients within the Last Decade
Christopher C. M. Neumann, Francois Schneider, Georg Hilfenhaus, Loredana Vecchione, Matthaeus Felsenstein, Jana Ihlow, Dominik Geisel, Steffen Sander, Johann Pratschke, Sebastian Stintzing, Ulrich Keilholz, Uwe Pelzer
CANCERS (2023)
Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
Timo Alexander Auer, Federico Collettini, Laura Segger, Uwe Pelzer, Raphael Mohr, Felix Krenzien, Bernhard Gebauer, Dominik Geisel, Clarissa Hosse, Wenzel Schoening, Uli Fehrenbach
CANCERS (2023)
Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial
Susanne Wiegand, Gunnar Wichmann, Jeannette Vogt, Kathrin Vogel, Annegret Franke, Thomas Kuhnt, Florian Lordick, Anne-Marie Scheuble, Peter Hambsch, Peter Brossart, Franz Georg Bauernfeind, Holger Kaftan, Georg Maschmeyer, Matthias Paland, Marc Muenter, Victor Lewitzki, Nicole Rotter, Carmen Stromberger, Marcus Beck, Steffen Dommerich, Thomas Christoph Gauler, Gunnar Hapke, Orlando Guntinas-Lichius, Ursula Schroeder, Martin Goerner, Matthias G. Hautmann, Felix Steger, Balint Tamaskovics, Anett Schmiedeknecht, Andreas Dietz
FRONTIERS IN ONCOLOGY (2023)
Phasic left atrial strain to predict worsening of diastolic function: Results from the prospective Berlin Female Risk Evaluation follow-up trial
Anna Brand, Elena Romero Dorta, Adrian Wolf, Daniela Blaschke-Waluga, Ute Seeland, Claudia Crayen, Sven Bischoff, Isabel Mattig, Henryk Dreger, Karl Stangl, Vera Regitz-Zagrosek, Ulf Landmesser, Fabian Knebel, Verena Stangl
FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)
Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it's not all about size
Johannes Kolck, Timo Alexander Auer, Thula Walter-Rittel, Clarissa Hosse, Aboelyazid Elkilany, Adrian Alexander Marth, Uwe Pelzer, Raphael Mohr, Felix Krenzien, Georg Lurje, Wenzel Schoening, Bernd Hamm, Dominik Geisel, Uli Fehrenbach
ABDOMINAL RADIOLOGY (2023)
Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5th edition of the World Health Organization classification
Timo A. Auer, Sebastian Halskov, Uli Fehrenbach, Nora F. Nevermann, Uwe Pelzer, Raphael Mohr, Bernd Hamm, Wenzel Schoening, David Horst, Jana Ihlow, Dominik Geisel
EUROPEAN RADIOLOGY (2023)
Perioperative outcome and long-term survival for intrahepatic cholangiocarcinoma after portal vein embolization and subsequent resection: A propensity-matched study
N. Nevermann, J. Bode, M. Vischer, F. Krenzien, G. Lurje, U. Pelzer, U. Fehrenbach, T. A. Auer, M. Schmelzle, J. Pratschke, W. Schoening
EJSO (2023)